Lupus Prognostic Profile
Also known as: SLE, Systemic Lupus Erythematosus Prognosis
Use
This profile is comprised of Anti-C1q Ab, Anti-Ribosomal P Ab, Anti-Cardiolipin Abs (IgG, IgA, IgM), Anti-Beta2 Glycoprotein I Abs (IgG, IgA, IgM) and Anti-PS/PT (Phosphatidylserine/Prothrombin) Complex Abs (IgG, IgM).
Special Instructions
Ensure serum is separated from cells within one hour of collection and transferred to a plastic transport tube before shipping. This protocol helps preserve sample integrity and ensures accurate results.
Limitations
The test has not been cleared or approved by the FDA. It is important to consider potential cross-reactivity or transient elevations due to infections or other conditions. Results should be interpreted in conjunction with other clinical findings and laboratory tests to confirm a diagnosis of systemic lupus erythematosus.
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 44702-9
- 13636-6
- 3181-5
- 5076-5
- 3182-3
- 21108-6
- 16135-6
- 16136-4
- 85359-8
- 85358-0
Result Turnaround Time
7-10 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
5 mL
Minimum Volume
4 mL
Container
Serum transfer tube, serum from a gel tube or serum from red-top tube
Collection Instructions
Separate serum from cells within one hour of collection. Transfer to a plastic transport tube before shipping.
Storage Instructions
Frozen
Stability Requirements
| Temperature | Period |
|---|---|
| Frozen | 14 days |